Valuation: Dynatronics Corporation

Market Cap 16 13.7 12.8 11.74 22.05 1.53T 22.51 151.74 59.16 764.89 60.07 58.77 2.54T P/E 2024
-0.26x
P/E 2025 -0.06x
Enterprise Value 63.04L 53.98L 50.44L 46.25L 86.89L 60Cr 88.68L 5.98Cr 2.33Cr 30Cr 2.37Cr 2.32Cr 100.27Cr EV / Sales 2024
0.23x
EV / Sales 2025 0.26x
Free-Float
47.39%
Yield 2024 *
-
Yield 2025 -
Current year 0
Extreme 1.0E-6
0.05
1 year 0
Extreme 1.0E-6
0.09
3 years 0
Extreme 1.0E-6
0.91
5 years 0
Extreme 1.0E-6
8.1
10 years 0
Extreme 1.0E-6
18.75
Manager TitleAgeSince
Chief Operating Officer 46 01/06/2023
Chief Tech/Sci/R&D Officer 57 25/07/2022
Date Insider Type Main position Quantity % Market Cap.
30/10/25 Others 13,405 0.1017%
30/10/25 Others

Chief Executive Officer

1,130 0.0086%
30/10/25
Provco Ventures I LP
OthersCompany 8,043 0.0610%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 16
+2.28%+4.07%+25.94%+17.88% 23TCr
+2.09%+4.92%+1.75%-14.12% 15TCr
-5.84%-6.68%-21.85%+30.96% 14TCr
-5.08%-3.99%-52.41%-1.63% 7.54TCr
-2.65%-3.46%+13.81%+17.30% 5.32TCr
-0.43%+2.00%-16.51%-12.52% 5.19TCr
+0.57%+5.44%+30.13%+31.07% 4.39TCr
-2.68%-2.75%+35.93%+49.89% 4.09TCr
-0.75%+2.46%+0.12%+8.34% 3.37TCr
Average -0.64%+1.24%+1.88%+14.13% 8.15TCr
Weighted average by Cap. +0.25%+1.31%+2.20%+12.44%

Financials

2024 2025
Net sales 3.25Cr 2.79Cr 2.6Cr 2.39Cr 4.48Cr 311.33Cr 4.58Cr 31Cr 12Cr 155.53Cr 12Cr 12Cr 517.44Cr 2.74Cr 2.35Cr 2.19Cr 2.01Cr 3.78Cr 262.14Cr 3.85Cr 26Cr 10Cr 130.95Cr 10Cr 10Cr 435.68Cr
Net income -26.98L -23.1L -21.58L -19.79L -37.18L -26Cr -37.95L -2.56Cr -99.74L -13Cr -1.01Cr -99.08L -43Cr -1.09Cr -93.35L -87.22L -79.99L -1.5Cr -104.32Cr -1.53Cr -10Cr -4.03Cr -52Cr -4.09Cr -4Cr -173.39Cr
Net Debt 62.04L 53.13L 49.64L 45.52L 85.51L 59Cr 87.27L 5.88Cr 2.29Cr 30Cr 2.33Cr 2.28Cr 99Cr 63.04L 53.98L 50.44L 46.25L 86.89L 60Cr 88.68L 5.98Cr 2.33Cr 30Cr 2.37Cr 2.32Cr 100.27Cr
Logo Dynatronics Corporation
Dynatronics Corporation is a medical device company. The Company designs, manufactures, and sells a range of products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. It markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. The Company's products are marketed under brands including Bird & Cronin, Solaris, Hausmann, PROTEAM, and Mammoth, among others. It offers a range of restorative products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. Its offerings include orthopedic soft bracing and supports, patient care products, treatment tables, rehabilitation equipment, therapeutic modalities, and related supplies. Its orthopedic soft bracing products are designed for patients both pre- and post-surgical intervention, and during fracture recovery, joint stabilization, and ligament injury.
Employees
88

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DYNTQ Stock